搜尋結果
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 6 日前... it is challenging hundreds of alleged "junk" patents held by pharmaceutical ... ...
What is Ozempic face and how can you avoid it?
South China Morning Post· 6 日前Known generically as semaglutide, Ozempic is a drug that works to treat type 2 diabetic ...
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
CNBC· 5 日前Johnson & Johnson baby powder is displayed in San Anselmo, California, on April 5, 2023. ...
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
CNBC· 4 日前Danish pharmaceutical giant Novo Nordisk, which became the most valuable company in Europe last ...
These are Mizuho’s top stock picks heading into May
CNBC· 3 日前Mizuho just released its top stock picks for May, and its basket of stocks includes three new ...
製藥商Amneal(AMRX.US)與美國就鴉片類藥物達成2.7億美元和解
阿思達克財經網· 3 日前Amneal Pharmaceuticals(AMRX.US)表示,已達成一項價值超過2.7億美元的協議,以解決有關其助長美國致命鴉...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 6 日前... challenging hundreds of alleged “junk” patent listings filed by several pharmaceutical ... ...
Five Low-Debt Stocks For The “Higher For Longer” Era
Forbes· 11 小時前Jerome Powell, head of the Federal Reserve, made it official a few days ago. “Higher for ...
Earnings will drive the market next week — what we expect from 2 portfolio stocks
CNBC· 2 日前Without any major economic reports, earnings — especially forward guidance and management ...
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Reuters· 6 日前Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals ...